VCYT
Veracyte Inc
48.50$
+10.8%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +9.7% | -157.7% | – | +1.3% | -18.2% | -78.1% | +526.7% | +33.2% | +17.5% | -33.0% | +30.1% | – | |
| – | -13.5% | -11.8% | +2.6% | +2.4% | +6.4% | -14.2% | +2.4% | -4.1% | +0.6% | +2.5% | -10.9% | – | |
| – | +3.4% | +6.7% | +22.9% | -11.2% | +10.1% | +13.8% | +0.2% | -2.1% | +1.3% | +17.1% | +10.4% | – | |
| – | – | -1,699.9% | – | -101.6% | – | – | – | +1,754.7% | -14.1% | -314.1% | – | – | |
| – | -10.9% | -14.5% | +29.8% | -19.1% | +84.7% | -56.1% | -29.3% | +117.1% | +54.5% | -31.3% | -3.5% | – | |
| – | -10.9% | – | -196.2% | -19.1% | +2,314.9% | -4.3% | -99.6% | – | -111.3% | +2,256.6% | -89.4% | – | |
| – | -53.9% | +240.0% | -66.0% | +67.3% | +50.2% | +188.7% | -74.8% | – | – | – | – | – | |
| – | +486.4% | -234.0% | -98.7% | – | -143.8% | +43.8% | -91.3% | – | -105.0% | +4,349.0% | – | – | |
| – | +23.8% | -150.4% | – | +42.7% | -190.5% | – | – | +187.8% | -51.1% | -311.5% | – | – | |
| – | +14.8% | -185.0% | – | +3.4% | -26.5% | -82.6% | +812.2% | +29.8% | +15.0% | -33.2% | +33.2% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.